manufacturing lentivirus and gamma-retrovirus vectors, ViroCell enables clients to start clinical trials on a scalable platform, delivering value by reducing costs, time and regulatory risk. For more information please visit, www.virocell.com
an innovative pharmaceutical company focused on developing best-in-class pharmaceuticals. The company integrates APIs and formulations, combining generic and innovative drugs to meet global clinical needs. BGM0504 is a dual GIP/GLP-1 receptor...
fusion technology, driving advancements that promise to create a safer, healthier, and more sustainable world. For more information please visit, https://www.shinefusion.com/
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the launch of a new sprinkle formulation of INGREZZA® (valbenazine) capsules, the #1 prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor indicated for the treatment of adults with...
in combination with fulvestrant. Once the recommended Phase 2 dose of the combination has been determined, there will be a formal evaluation of efficacy in an expansion cohort. "We are thrilled to have dosed the first patient with BTX-9341 at The...
The U.S. $749,999 contract, awarded through a highly competitive review process, supports early-stage therapeutic platform development for the Flexible and Strategic Therapeutics (FASTx) program of BARDA. This initiative aims to advance...
novel unconjugated antisense oligonucleotide (ASO) developed within AusperBio's proprietary Med-Oligo™ ASO technology platform, was designed to treat chronic hepatitis B for a functional cure. Its compelling preclinical data was highlighted at the...
immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ). Lecanemab is also approved in the U.S., Japan, China, and South Korea. About BioArctic AB: BioArctic AB...
retinal treatments, and lays the groundwork for future advancements.” Susvimo provides continuous delivery of a customized formulation of ranibizumab via the Port Delivery Platform, while other currently approved treatments may require multiple eye...
and Phase Ib/II in combination with MSD's pembrolizumab PMC-309 + Pembrolizumab combo is in plan. For additional information about PharmAbcine, visit http://www.pharmabcine.com
and Japan, with AbbVie responsible for further global commercialization. FL is typically an indolent (or slow-growing) form of non-Hodgkin's lymphoma (NHL) that arises from B-lymphocytes and is the second most common form of NHL accounting for...
Pines Therapeutics and the Harvard CBR Institute for Biomedical Research, and is headquartered in La Jolla, CA. For more information, please visit www.calcimedica.com.
value of all four serotypes of dengue virus as well as Zika, Chikungunya, and Yellow Fever viruses. Hyundai Bioscience has formulated the multi-treatment antiviral into a tablet form to facilitate mass production and to make it convenient for...
for Soldier rations and micronutrient delivery, leveraging Smart Cups' cutting-edge printing technology for enhanced performance and nutrition in military settings. Smart Cups also announced an exclusive two-year deal with Compana Pet Brands, a...
Rigaku we are focused on supporting our clients with our global expertise and development of innovative solutions that perform optimally, mitigate new chemical threats, and are always reliable and cost effective. Understanding the austere...
overdose from high doses of potent synthetic opioids, compared to a 4 mg dose of IN naloxone. Model simulations were performed using a validated translational model1 developed by the Division of Applied Regulatory Science in the US Food and Drug...
enrollment later this year. About BioMarin: Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root...
rights for a range of MTF Biologics’ tissue technologies, including placental, dermal, and adipose tissues. The tissue forms covered in the agreement include Amnioband® Membrane, Salera® Membrane, Salera® Mini-Membrane, Allopatch® Pliable,...
and ISO 14001 certified, and operates in a 95,000 square-foot facility with an ISO-8 Class 100,000 Cleanroom. For more information please visit, www.qosmedix.com.
patients. "Immorta Bio is a Scientific Longevity Company. In that regard we are developing two longevity therapeutics platforms: Cellular Rejuvenation and Senolytic Immunotherapy (SenoVax™)," said Dr. Boris Reznik, Chairman and CEO of Immorta Bio....
